跳至主要内容
临床试验/NCT00330434
NCT00330434撤回不适用

Human CYP2B6: Induction by Ethanol and Polymorphisms

Tufts University2 个研究点 分布在 1 个国家开始时间: 2005年12月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
试验地点
2

研究概览

简要总结

The two purposes of this study are

  1. to determine what effect the chronic and moderate/heavy drinking of alcoholic beverages has

  2. on the blood level of bupropion and chlorzoxazone and their major breakdown products in the blood and

  3. on the stimulant effect of bupropion and

  4. to determine what effect a normal and common (25% frequency) genetic variation of a specific liver enzyme (that breaks down bupropion) has

  5. on the blood levels of bupropion and its major breakdown products in the blood and

  6. on the stimulant effect of bupropion.

Two groups of volunteers will be recruited for this study:

  1. volunteers who drink moderate to heavy amounts of alcohol frequently and
  2. volunteers who usually do not drink alcohol.

Volunteers will NOT be asked to change their drinking (or nondrinking) habits during the study.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
21 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy adults who are 21 - 55 years of age.
  • Either 1) Moderate-to-heavy drinkers who drink on average more than 14 but less than 28 drinks per week; OR 2) adults who normally abstain from drinking alcohol.

排除标准

  • Participants who are currently taking prescription medications (including oral contraceptives)
  • Pregnancy
  • Body mass index (BMI) greater than 30
  • History of seizures or eating disorders

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验